Acceleron Pharma Inc
XLRNDelisted Nov 22, 2021- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001280600
Acceleron Pharma Inc was delisted on Nov 22, 2021; its insiders filed their last Form 4 on Nov 22, 2021; 333 institutions reported holding it in 13F filings for Q3 2021, worth $9.22B in total; no superinvestor held it.
Holders of 5% or more of XLRN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Acceleron Pharma Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Acceleron Pharma Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Acceleron Pharma Inc, newest first.
No Schedule 13D or 13G filings on Acceleron Pharma Inc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Acceleron Pharma Inc shares.
No Form 144 notices for Acceleron Pharma Inc are on file.